We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

61 hedge funds and large institutions have $12.6M invested in ALX Oncology in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 32 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

586% more call options, than puts

Call options by funds: $48K | Put options by funds: $7K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10.75% less ownership

Funds ownership: 65.2% → 54.45% (-11%)

28% less funds holding

Funds holding: 85 → 61 (-24)

43% less capital invested

Capital invested by funds: $22.1M → $12.6M (-$9.55M)

71% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 34

72% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 32

Holders
61
Holders Change
-24
Holders Change %
-28.24%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
9
Reduced
32
Closed
34
Calls
$48K
Puts
$7K
Net Calls
+$41K
Net Calls Change
+$74K

Top Buyers

Rank Fund Capital Flow
1
AC
Almitas Capital
California
+$598K
2
Jane Street
Jane Street
New York
+$103K
3
GCP
GSA Capital Partners
United Kingdom
+$41K
4
Renaissance Technologies
Renaissance Technologies
New York
+$35.9K
5
Squarepoint
Squarepoint
New York
+$29.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$806K
2
MB
MPM BioImpact
Massachusetts
-$343K
3
State Street
State Street
Massachusetts
-$300K
4
Los Angeles Capital Management
Los Angeles Capital Management
California
-$255K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
76
SG Americas Securities
New York
– -$14K -22,277 Closed
FFM
77
Forum Financial Management
Illinois
– -$13.7K -22,051 Closed
Mirae Asset Global ETFs Holdings
78
Mirae Asset Global ETFs Holdings
Hong Kong
– -$12.3K -19,771 Closed
KAM
79
Kazazian Asset Management
Florida
– -$11.8K -19,000 Closed
CF
80
Corebridge Financial
Texas
– -$10.5K -16,878 Closed
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
– -$7.8K -12,522 Closed
T. Rowe Price Associates
82
T. Rowe Price Associates
Maryland
– -$7K -10,622 Closed
Mercer Global Advisors
83
Mercer Global Advisors
Colorado
– -$6.28K -10,077 Closed
PFSRSONJ
84
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$3.83K -6,148 Closed
SO
85
STRS Ohio
Ohio
– -$2.55K -4,100 Closed
Legal & General Group
86
Legal & General Group
United Kingdom
– -$2.4K -3,860 Closed
AIP
87
Ameritas Investment Partners
Nebraska
– -$1.74K -2,790 Closed
California State Teachers Retirement System (CalSTRS)
88
California State Teachers Retirement System (CalSTRS)
California
– -$1.49K -2,393 Closed
Citadel Advisors
89
Citadel Advisors
Florida
– -$1.11K -2,209 Closed
AB
90
Amalgamated Bank
New York
– -$1K -897 Closed
Simplex Trading
91
Simplex Trading
Illinois
– -$197 -391 Closed
RIL
92
Rothschild Investment LLC
Illinois
– -$140 -225 Closed
CIAM
93
Caitong International Asset Management
Hong Kong
– -$74 -119 Closed
Osaic Holdings
94
Osaic Holdings
Arizona
– -$62 -100 Closed
SCM
95
Sterling Capital Management
North Carolina
– -$21 -34 Closed
1 2 3
4

ALXO Hedge Fund Activity: Q2 2025 in Review

61 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q2 2025, worth a combined $12.6M — down 43% from $22.1M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of ALXO and 10 opened new positions — a net loss of 24 holders — while 32 trimmed existing stakes and 9 added.

The largest buyer was Almitas Capital, adding an estimated $598K. The largest seller was BlackRock, cutting an estimated $806K.

  • 61 institutional investors held ALX Oncology (ALXO) as of Q2 2025, down from 85 in Q1 2025.
  • Funds reported $12.6M of ALX Oncology stock for Q2 2025, down 43% quarter-over-quarter.
  • 10 funds opened new ALX Oncology positions in Q2 2025 and 34 closed out, a net change of -24 holders.
  • The largest ALX Oncology buyer in Q2 2025 was Almitas Capital, an estimated $598K added.
  • The largest ALX Oncology seller in Q2 2025 was BlackRock, an estimated $806K sold.

Based on aggregated 13F filings for Q2 2025.